References
- Chwieduk CM, Keating GM. Paliperidone extended release: a review of its use in the management of schizophrenia. Drugs 2010; 70: 1295–1317.
- Invega® (paliperidone) Extended-Release Tablets [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc., June 2011.
- Levine M, Lovecchio F, Tafoya P, Graham R. Paliperidone overdose with delayed onset of toxicity. Ann Emerg Med 2011; 58:80–82.
- Chang JP, Huang CC, Su KP. Paliperidone overdose in a patient with schizophrenia. Prog Neuropyschopharmacol Biol Psychiatry 2010; 34:418.
- Gill JS, Pillai SK, Koh OH, Jambunathan S. Non-fatal paliperidone overdose: a case report. Turkish J Psychiatry 2010; 21:331–334.
- Lapid MI, Cunningham JL, Hugo Z, Kung S. Acute dystonia associated with paliperidone overdose. Psychosomatics 2011; 52:291–294.
- Liang CS, Bai YM, Liou YJ, Chou YH. Acute renal failure after paliperidone overdose: a case report. J Clin Psychopharmacology 2012; 32:128.
- Seeman P. An update of fast-off dopamine D2 atypical antipsychotics. Am J Psychiatry 2005; 162:1984–1985.
- Page CB, Calver LA, Isbister GK. Risperidone overdose causes extrapyramidal effects but not cardiac toxicity. J Clin Psychopharmacol 2010; 30:387–390.
- Risperdal®, Risperdal® M-TAB® (risperidone) tablets, oral solution, and orally disintegrating tablets [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc., Nov 2013.
- Jaramillo JE, Marchbanks B, Willis B, Forrester MB. Evaluation of completeness of selected poison control center data fields. J Med Syst 2010; 34:499–507.